Company at a Glance
Price
Overview
Kyowa Kirin is a global specialty pharmaceutical company that focuses on research and development, manufacturing, and commercialization of prescription drugs and consumer healthcare products. The company was founded in 1949 in Tokyo, Japan as Kyowa Hakko Kogyo Co., Ltd. and changed its name to Kyowa Kirin Co., Ltd. in 2008.
They have a presence in over 30 countries worldwide, with a significant presence in the United States, Europe, and Asia. Kyowa Kirin is known for its focus on rare diseases, oncology, and neuroscience, as well as for its strong research and development capabilities.
The company's mission is to contribute to the health and well-being of people around the world through innovative pharmaceutical and healthcare products. Their core values include putting patients first, promoting diversity and inclusion, and being a responsible corporate citizen.
Kyowa Kirin has a diverse portfolio of prescription drugs, over-the-counter products, and medical devices. Some of their notable products include the biologic therapies Poteligeo and Crysvita, used to treat rare diseases, and the popular gastrointestinal medicine Nexium.
In addition to its pharmaceutical business, Kyowa Kirin also has a consumer healthcare division that offers a range of self-care products, including pain relief patches, digestive health supplements, and cold and flu remedies.
The company has a strong commitment to sustainability and corporate responsibility, with initiatives focused on reducing its environmental impact, promoting gender equality and diversity, and supporting local communities through various philanthropic activities.
Overall, Kyowa Kirin is a prominent player in the pharmaceutical industry, known for its dedication to improving the lives of patients and for its strong presence in both established and emerging markets.
How to explain to a 10 year old kid about the company?
π Want to read more about Kyowa Kirin?
Sign up for free
or
log in
βοΈ Sign up to get "The Checklist Value Investor β A Smarter Way to Pick Stocks" for free
S3lvd2EgS2 lyaW4gaXMg YSBjb21wYW 55IHRoYXQg bWFrZXMgbW VkaWNpbmUg YW5kIG90aG VyIGhlYWx0 aC1yZWxhdG VkIHByb2R1 Y3RzLiBUaG V5IGZvY3Vz IG9uIGZpbm RpbmcgbmV3 IHdheXMgdG 8gaGVscCBw ZW9wbGUgd2 hvIGFyZSBz aWNrIG9yIG hhdmUgcHJv YmxlbXMgd2 l0aCB0aGVp ciBoZWFsdG guIFRoZWly IGdvYWwgaX MgdG8gY3Jl YXRlIHRyZW F0bWVudHMg dGhhdCBpbX Byb3ZlIHBl b3BsZeKAmX MgbGl2ZXMu PGJyPkt5b3 dhIEtpcmlu IG1ha2VzIG 1vbmV5IGJ5 IHNlbGxpbm cgdGhlc2Ug bWVkaWNpbm VzIHRvIGhv c3BpdGFscy wgcGhhcm1h Y2llcywgYW 5kIGRvY3Rv cnMgd2hvIG hlbHAgcGF0 aWVudHMuIF doZW4gZG9j dG9ycyB1c2 UgdGhlaXIg bWVkaWNpbm VzIHRvIHRy ZWF0IHBhdG llbnRzLCB0 aGUgY29tcG FueSBlYXJu cyBtb25leS 4gVGhleSBh bHNvIGdldC BwYWlkIGJ5 IGluc3VyYW 5jZSBjb21w YW5pZXMgdG hhdCBjb3Zl ciB0aGUgY2 9zdHMgb2Yg dGhlIG1lZG ljaW5lIGZv ciB0aGUgcG F0aWVudHMu PGJyPk9uZS ByZWFzb24g S3lvd2EgS2 lyaW4gaXMg c3VjY2Vzc2 Z1bCBpcyBi ZWNhdXNlIH RoZXkgc3Bl bmQgYSBsb3 Qgb2YgdGlt ZSBhbmQgbW 9uZXkgb24g cmVzZWFyY2 guIFRoaXMg bWVhbnMgdG hleSBsb29r IGZvciBuZX cgaWRlYXMg YW5kIHdheX MgdG8gbWFr ZSBiZXR0ZX IgbWVkaWNp bmVzLiBUaG V5IHdvcmsg aGFyZCB0by B1bmRlcnN0 YW5kIGRpc2 Vhc2VzIGFu ZCBob3cgdG 8gaGVscCBw ZW9wbGUgZm VlbCBiZXR0 ZXIuIEJlaW 5nIGdvb2Qg YXQgcmVzZW FyY2ggaGVs cHMgdGhlbS BjcmVhdGUg dW5pcXVlIH RyZWF0bWVu dHMgdGhhdC BhcmUgbm90 IGF2YWlsYW JsZSBmcm9t IG90aGVyIG NvbXBhbmll cy48YnI+SW 4gdGhlIGZ1 dHVyZSwgS3 lvd2EgS2ly aW4gaXMgbG lrZWx5IHRv IHN0YXkgc3 VjY2Vzc2Z1 bCBiZWNhdX NlIHRoZXkg aGF2ZSBhIH N0cm9uZyB0 ZWFtIG9mIH NjaWVudGlz dHMgYW5kIH Jlc2VhcmNo ZXJzIHdoby BrZWVwIGNv bWluZyB1cC B3aXRoIG5l dyBpZGVhcy 4gUGx1cywg YXMgbW9yZS BwZW9wbGUg YXJvdW5kIH RoZSB3b3Js ZCBuZWVkIG hlbHAgd2l0 aCB0aGVpci BoZWFsdGgs IHRoZSBkZW 1hbmQgZm9y IGdvb2QgbW VkaWNpbmVz IHdpbGwgZ3 Jvdy4gVGhp cyBtZWFucy B0aGUgY29t cGFueSBjYW 4gY29udGlu dWUgdG8gaG VscCBtYW55 IHBlb3BsZS BhbmQgZWFy biBtb25leS 4gQXMgbG9u ZyBhcyB0aG V5IGtlZXAg YmVpbmcgaW 5ub3ZhdGl2 ZSBhbmQgZm 9jdXNpbmcg b24gaGVscG luZyBvdGhl cnMsIHRoZX kgYXJlIGxp a2VseSB0by ByZW1haW4g c3VjY2Vzc2 Z1bC48YnI+
What is special about the company?
π Want to read more about Kyowa Kirin?
Sign up for free
or
log in
π Unlock our free guide: "The Checklist Value Investor β A Smarter Way to Pick Stocks"
MS4gR2xvYm FsIFByZXNl bmNlOiBLeW 93YSBLaXJp biBoYXMgYS BzdHJvbmcg Z2xvYmFsIH ByZXNlbmNl IHdpdGggb3 BlcmF0aW9u cyBpbiBtb3 JlIHRoYW4g MjggY291bn RyaWVzLCBp bmNsdWRpbm cgSmFwYW4s IHRoZSBVbm l0ZWQgU3Rh dGVzLCBhbm QgRXVyb3Bl LiBUaGlzIG FsbG93cyB0 aGUgY29tcG FueSB0byBy ZWFjaCBhIG RpdmVyc2Ug bWFya2V0IG FuZCBjYXRl ciB0byB0aG UgbmVlZHMg b2YgZGlmZm VyZW50IHBv cHVsYXRpb2 5zLjxicj4y LiBGb2N1cy BvbiBSYXJl IERpc2Vhc2 VzOiBLeW93 YSBLaXJpbi BzcGVjaWFs aXplcyBpbi BkZXZlbG9w aW5nIGFuZC BtYW51ZmFj dHVyaW5nIH RyZWF0bWVu dHMgZm9yIH JhcmUgZGlz ZWFzZXMgdG hhdCBoYXZl IGEgc2lnbm lmaWNhbnQg dW5tZXQgbW VkaWNhbCBu ZWVkLiBJdC BpcyBvbmUg b2YgdGhlIG ZldyBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMgd2 l0aCBhIHN0 cm9uZyBmb2 N1cyBvbiB0 aGlzIG5pY2 hlIGFyZWEu PGJyPjMuIE V4cGVydGlz ZSBpbiBCaW 9sb2dpY3M6 IEt5b3dhIE tpcmluIGlz IGEgcGlvbm VlciBpbiB0 aGUgZGV2ZW xvcG1lbnQg b2YgYmlvbG 9naWMgZHJ1 Z3MsIHdoaW NoIGFyZSBk ZXJpdmVkIG Zyb20gbGl2 aW5nIG9yZ2 FuaXNtcyBh bmQgY2FuIG hhdmUgYSBz aWduaWZpY2 FudCBpbXBh Y3Qgb24gdH JlYXRpbmcg cmFyZSBkaX NlYXNlcyBh bmQgaW1wcm 92aW5nIHBh dGllbnRzJy BsaXZlcy48 YnI+NC4gU3 Ryb25nIFIm RCBGb2N1cz ogVGhlIGNv bXBhbnkgaG FzIGEgcm9i dXN0IHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCAo UiZEKSBwcm 9ncmFtLCB3 aXRoIGEgZG VkaWNhdGVk IHRlYW0gb2 Ygc2NpZW50 aXN0cyBhbm QgcmVzZWFy Y2hlcnMgY2 9udGludWFs bHkgd29ya2 luZyB0byBk aXNjb3Zlci BhbmQgZGV2 ZWxvcCBuZX cgdHJlYXRt ZW50cyBmb3 IgcmFyZSBk aXNlYXNlcy 48YnI+NS4g U3RyYXRlZ2 ljIFBhcnRu ZXJzaGlwcz ogS3lvd2Eg S2lyaW4gaG FzIGVzdGFi bGlzaGVkIH N0cmF0ZWdp YyBwYXJ0bm Vyc2hpcHMg d2l0aCBvdG hlciBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMgYW 5kIHJlc2Vh cmNoIGluc3 RpdHV0aW9u cyB0byBhZH ZhbmNlIHRo ZSBkZXZlbG 9wbWVudCBv ZiBuZXcgdH JlYXRtZW50 cyBmb3Igcm FyZSBkaXNl YXNlcy48Yn I+Ni4gUGF0 aWVudC1DZW 50cmljIEFw cHJvYWNoOi BUaGUgY29t cGFueSBoYX MgYSBwYXRp ZW50LWNlbn RyaWMgYXBw cm9hY2gsIH doaWNoIG1l YW5zIHRoYX QgaXQgaW52 b2x2ZXMgcG F0aWVudHMg aW4gdGhlIG RldmVsb3Bt ZW50IGFuZC BpbXBsZW1l bnRhdGlvbi BvZiB0cmVh dG1lbnRzIG Zyb20gdGhl IGVhcmx5IH N0YWdlcywg ZW5zdXJpbm cgdGhhdCB0 aGVpciBuZW VkcyBhbmQg cHJlZmVyZW 5jZXMgYXJl IGNvbnNpZG VyZWQuPGJy PjcuIFN0cm 9uZyBFdGhp Y2FsIFN0YW 5kYXJkczog S3lvd2EgS2 lyaW4gaXMg Y29tbWl0dG VkIHRvIGV0 aGljYWwgc3 RhbmRhcmRz IGFuZCBoYX MgYSBjb3Jw b3JhdGUgcG hpbG9zb3Bo eSBvZiAibW FraW5nIHRo ZSBoZWFsdG ggYW5kIHdl bGwtYmVpbm cgb2YgcGVv cGxlIHRoZS BmaXJzdCBw cmlvcml0eS 4iPGJyPjgu IFN1c3RhaW 5hYmlsaXR5 IEluaXRpYX RpdmVzOiBU aGUgY29tcG FueSBpcyBh Y3RpdmVseS BpbnZvbHZl ZCBpbiBzdX N0YWluYWJp bGl0eSBpbm l0aWF0aXZl cywgaW5jbH VkaW5nIHJl ZHVjaW5nIG l0cyBjYXJi b24gZm9vdH ByaW50IGFu ZCBzdXBwb3 J0aW5nIGxv Y2FsIGNvbW 11bml0aWVz Ljxicj45Li BEaXZlcnNp ZmllZCBQb3 J0Zm9saW86 IEt5b3dhIE tpcmluIGhh cyBhIGRpdm Vyc2UgcHJv ZHVjdCBwb3 J0Zm9saW8g dGhhdCBpbm NsdWRlcyBw cmVzY3JpcH Rpb24gZHJ1 Z3MsIG92ZX ItdGhlLWNv dW50ZXIgbW VkaWNpbmVz LCBhbmQgY2 9uc3VtZXIg aGVhbHRoY2 FyZSBwcm9k dWN0cywgYW xsb3dpbmcg aXQgdG8gY2 F0ZXIgdG8g dGhlIG5lZW RzIG9mIGRp ZmZlcmVudC BwYXRpZW50 IHBvcHVsYX Rpb25zLjxi cj4xMC4gU3 Ryb25nIEZp bmFuY2lhbC BQZXJmb3Jt YW5jZTogVG hlIGNvbXBh bnkgaGFzIG NvbnNpc3Rl bnRseSBzaG 93biBzdHJv bmcgZmluYW 5jaWFsIHBl cmZvcm1hbm NlLCB3aXRo IGEgZm9jdX Mgb24gc3Vz dGFpbmFibG UgZ3Jvd3Ro IGFuZCBsb2 5nLXRlcm0g dmFsdWUgY3 JlYXRpb24g Zm9yIGl0cy BzaGFyZWhv bGRlcnMu
What the company's business model?
π Want to read more about Kyowa Kirin?
Sign up for free
or
log in
β
Download "The Checklist Value Investor β A Smarter Way to Pick Stocks" β totally free!
S3lvd2EgS2 lyaW4gaXMg YSBnbG9iYW wgc3BlY2lh bHR5IHBoYX JtYWNldXRp Y2FsIGNvbX BhbnkgdGhh dCBmb2N1c2 VzIG9uIGRl dmVsb3Bpbm csIG1hbnVm YWN0dXJpbm csIGFuZCBt YXJrZXRpbm cgaW5ub3Zh dGl2ZSBtZW RpY2luZXMg YW5kIGhlYW x0aGNhcmUg cHJvZHVjdH MuIEl0cyBi dXNpbmVzcy Btb2RlbCBj YW4gYmUgZG VmaW5lZCBh cyBmb2xsb3 dzOjxicj4x LiBSZXNlYX JjaCBhbmQg RGV2ZWxvcG 1lbnQ6IEt5 b3dhIEtpcm luIGludmVz dHMgYSBzaW duaWZpY2Fu dCBhbW91bn Qgb2YgcmVz b3VyY2VzIG luIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCAoUi ZEKSBhY3Rp dml0aWVzIH RvIGRpc2Nv dmVyIGFuZC BkZXZlbG9w IG5ldyBkcn VncyBhbmQg dGhlcmFwZX V0aWMgdHJl YXRtZW50cy 4gVGhlIGNv bXBhbnkgaG FzIGEgc3Ry b25nIHBpcG VsaW5lIG9m IHBvdGVudG lhbCBuZXcg cHJvZHVjdH MgaW4gdmFy aW91cyBzdG FnZXMgb2Yg ZGV2ZWxvcG 1lbnQuPGJy PjIuIE1hbn VmYWN0dXJp bmc6IEt5b3 dhIEtpcmlu IGhhcyBtYW 51ZmFjdHVy aW5nIGZhY2 lsaXRpZXMg Zm9yIHBoYX JtYWNldXRp Y2FscywgYm lvbG9naWNz LCBhbmQgbW VkaWNhbCBk ZXZpY2VzIG luIEphcGFu LCB0aGUgVW 5pdGVkIFN0 YXRlcywgYW 5kIEV1cm9w ZS4gVGhlIG NvbXBhbnkg ZW5zdXJlcy BoaWdoLXF1 YWxpdHkgcH JvZHVjdGlv biBzdGFuZG FyZHMgYW5k IGVmZmljaW VudCBzdXBw bHkgY2hhaW 4gbWFuYWdl bWVudCB0by BtZWV0IHRo ZSBkZW1hbm QgZm9yIGl0 cyBwcm9kdW N0cy48YnI+ My4gTWFya2 V0aW5nIGFu ZCBTYWxlcz ogS3lvd2Eg S2lyaW4ncy Bwcm9kdWN0 cyBhcmUgbW Fya2V0ZWQg YW5kIHNvbG QgZ2xvYmFs bHkgdGhyb3 VnaCBpdHMg b3duIHNhbG VzIHRlYW1z LCBhcyB3ZW xsIGFzIHRo cm91Z2ggc3 RyYXRlZ2lj IHBhcnRuZX JzaGlwcyBh bmQgY29sbG Fib3JhdGlv bnMgd2l0aC BvdGhlciBw aGFybWFjZX V0aWNhbCBj b21wYW5pZX MuIFRoZSBj b21wYW55J3 MgbWFya2V0 aW5nIHN0cm F0ZWd5IGZv Y3VzZXMgb2 4gYnVpbGRp bmcgc3Ryb2 5nIHJlbGF0 aW9uc2hpcH Mgd2l0aCBo ZWFsdGhjYX JlIHByb2Zl c3Npb25hbH MgYW5kIGNy ZWF0aW5nIG F3YXJlbmVz cyBhYm91dC BpdHMgcHJv ZHVjdHMgYW 1vbmcgcGF0 aWVudHMuPG JyPjQuIEdl b2dyYXBoaW MgRGl2ZXJz aWZpY2F0aW 9uOiBUaGUg Y29tcGFueS BoYXMgYSBn bG9iYWwgcH Jlc2VuY2Ug d2l0aCBvcG VyYXRpb25z IGluIEFzaW EsIE5vcnRo IEFtZXJpY2 EsIGFuZCBF dXJvcGUuIF RoaXMgZ2Vv Z3JhcGhpYy BkaXZlcnNp ZmljYXRpb2 4gaGVscHMg S3lvd2EgS2 lyaW4gbWl0 aWdhdGUgcm lza3MgYXNz b2NpYXRlZC B3aXRoIHJl Z2lvbmFsIG Vjb25vbWlj IGFuZCBwb2 xpdGljYWwg ZmFjdG9ycy wgYXMgd2Vs bCBhcyBiZW 5lZml0IGZy b20gdGhlIG dyb3dpbmcg ZGVtYW5kIG ZvciBoZWFs dGhjYXJlIH Byb2R1Y3Rz IGluIGRpZm ZlcmVudCBy ZWdpb25zLj xicj41LiBU aGVyYXBldX RpYyBGb2N1 czogS3lvd2 EgS2lyaW4g aGFzIGV4cG VydGlzZSBp biBkZXZlbG 9waW5nIG1l ZGljaW5lcy BhbmQgdHJl YXRtZW50cy BpbiBmb3Vy IG1haW4gdG hlcmFwZXV0 aWMgYXJlYX M6IG5lcGhy b2xvZ3ksIG 9uY29sb2d5 LCBpbW11bm 9sb2d5L2Fs bGVyZ3ksIG FuZCBjZW50 cmFsIG5lcn ZvdXMgc3lz dGVtIGRpc2 9yZGVycy4g VGhpcyBmb2 N1cyBhbGxv d3MgdGhlIG NvbXBhbnkg dG8gbGV2ZX JhZ2UgaXRz IHNjaWVudG lmaWMga25v d2xlZGdlIG FuZCByZXNv dXJjZXMgdG 8gY3JlYXRl IGhpZ2hseS BlZmZlY3Rp dmUgcHJvZH VjdHMgaW4g dGhlc2UgYX JlYXMuPGJy PjYuIENvbG xhYm9yYXRp dmUgQXBwcm 9hY2g6IEt5 b3dhIEtpcm luIGNvbGxh Ym9yYXRlcy B3aXRoIGFj YWRlbWljIG luc3RpdHV0 aW9ucywgcm VzZWFyY2gg b3JnYW5pem F0aW9ucywg YW5kIG90aG VyIGJpb3Bo YXJtYWNldX RpY2FsIGNv bXBhbmllcy B0byBzaGFy ZSBrbm93bG VkZ2UsIGV4 cGVydGlzZS wgYW5kIHJl c291cmNlcy BpbiBSJkQu IFRoaXMgY2 9sbGFib3Jh dGl2ZSBhcH Byb2FjaCBo ZWxwcyB0aG UgY29tcGFu eSBhY2NlbG VyYXRlIGRy dWcgZGlzY2 92ZXJ5IGFu ZCBkZXZlbG 9wbWVudCBw cm9jZXNzZX MuPGJyPjcu IENvcnBvcm F0ZSBTb2Np YWwgUmVzcG 9uc2liaWxp dHk6IEt5b3 dhIEtpcmlu IGlzIGNvbW 1pdHRlZCB0 byBiZWluZy BhIHNvY2lh bGx5IHJlc3 BvbnNpYmxl IGNvbXBhbn kuIEl0IGFp bXMgdG8gaW 1wcm92ZSBh Y2Nlc3MgdG 8gaGVhbHRo Y2FyZSBhbm QgY29udHJp YnV0ZSB0by Bzb2NpZXR5 IHRocm91Z2 ggdmFyaW91 cyBpbml0aW F0aXZlcywg c3VjaCBhcy BwYXRpZW50 IGFzc2lzdG FuY2UgcHJv Z3JhbXMsIG Rpc2Vhc2Ug YXdhcmVuZX NzIGNhbXBh aWducywgYW 5kIHN1c3Rh aW5hYmxlIG J1c2luZXNz IHByYWN0aW Nlcy48YnI+ SW4gc3VtbW FyeSwgS3lv d2EgS2lyaW 4ncyBidXNp bmVzcyBtb2 RlbCBjb21i aW5lcyBhIH N0cm9uZyBm b2N1cyBvbi BSJkQgYW5k IG1hbnVmYW N0dXJpbmcg d2l0aCBhIG dsb2JhbCBt YXJrZXQgcH Jlc2VuY2Us IHN0cmF0ZW dpYyBwYXJ0 bmVyc2hpcH MsIGFuZCBh IGNvbW1pdG 1lbnQgdG8g Y29ycG9yYX RlIHNvY2lh bCByZXNwb2 5zaWJpbGl0 eS4gVGhpcy BhcHByb2Fj aCBhbGxvd3 MgdGhlIGNv bXBhbnkgdG 8gZGV2ZWxv cCBhbmQgcH JvdmlkZSBp bm5vdmF0aX ZlIGhlYWx0 aGNhcmUgcH JvZHVjdHMg dG8gbWVldC B0aGUgbmVl ZHMgb2YgcG F0aWVudHMg YW5kIGhlYW x0aGNhcmUg cHJvZmVzc2 lvbmFscyB3 b3JsZHdpZG Uu
Is AI a threat?
AI has the potential to impact the pharmaceutical and biotechnology sector, including companies like Kyowa Kirin, in several ways. Here are some considerations regarding how AI might pose a material threat:
1. Substitution: AI can lead to the development of new treatments or therapies that could substitute existing products. For instance, advancements in AI-driven drug discovery may enable the rapid identification of novel compounds, potentially leading to more effective treatments that compete directly with Kyowa Kirinβs offerings. Additionally, AI could facilitate personalized medicine approaches that tailor treatments to individual patients, possibly rendering some existing products less relevant.
2. Disintermediation: AI technologies are enabling a more direct connection between patients and therapies, potentially reducing the need for intermediaries like traditional healthcare providers. Telemedicine and AI-driven diagnostic tools allow patients to access information and care without always going through established pharmaceutical sales and distribution channels. This shift could disrupt how Kyowa Kirin delivers its services and engages with healthcare professionals.
3. Margin Pressure: As AI becomes integrated into drug development and clinical practices, the cost structure of bringing new drugs to market may evolve. Increased efficiency in drug development can enable competitors to produce treatments more quickly and at lower costs. With enhanced competition from AI-optimized companies, there may be downward pressure on pricing and profit margins for Kyowa Kirinβs products.
4. Data Utilization: AI can leverage large datasets to improve clinical outcomes and patient engagement. Companies that effectively use AI to analyze patient data and improve drug efficacy may gain a competitive edge over traditional methods employed by firms like Kyowa Kirin. If competitors harness AI effectively, it could outpace Kyowa Kirin in innovative applications and market relevance.
5. Regulatory Challenges: The integration of AI into healthcare may also bring regulatory challenges. Companies that are able to navigate these challenges and leverage AI effectively may gain advantages over others that are slower to adapt, including Kyowa Kirin.
In summary, while AI presents numerous opportunities for innovation within the pharmaceutical industry, it also poses material threats through potential substitution of products, disintermediation of services, and pressure on margins. Adapting to these challenges will be crucial for Kyowa Kirin to maintain its competitive positioning.
Sensitivity to interest rates
The sensitivity of Kyowa Kirinβs earnings, cash flow, and valuation to changes in interest rates can be assessed from various angles:
1. Earnings Sensitivity: Interest rates can impact the companyβs earnings through several channels. If Kyowa Kirin has variable-rate debt, an increase in interest rates could lead to higher interest expenses, thereby reducing net income. Conversely, lower interest rates could reduce these expenses and improve earnings.
2. Cash Flow Sensitivity: Similar to earnings, cash flows can be affected by interest rate fluctuations. Higher interest expenses can constrain operational cash flows, especially if the company has significant debt. Additionally, if Kyowa Kirin relies on financing for research and development, higher rates could increase the cost of financing, potentially reducing free cash flow.
3. Valuation Sensitivity: The valuation of Kyowa Kirin is often assessed through discounted cash flow (DCF) models, which use interest rates as a key input for the discount rate. An increase in interest rates raises the discount rate, reducing the present value of future cash flows and thus the valuation of the company. Conversely, a decrease in rates can enhance valuation.
Overall, while Kyowa Kirinβs specific sensitivity to interest rate changes would depend on its capital structure, debt levels, and operational efficiency, generally rising rates tend to negatively impact earnings, cash flow, and valuation due to increased borrowing costs and higher discount rates in valuation models.
Resilience to the future changes
π Want to read more about Kyowa Kirin?
Sign up for free
or
log in
π Your free copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks" is waiting
QSByZWFsaX N0aWMgc2Nl bmFyaW8gdG hhdCBjb3Vs ZCBwZXJtYW 5lbnRseSBp bXBhaXIgS3 lvd2EgS2ly aW7igJlzIG Vjb25vbWlj cyBvdmVyIH RoZSBuZXh0 IDPigJM1IH llYXJzIGlz IHRoZSBmYW lsdXJlIG9m IGl0cyBrZX kgZHJ1ZyBw aXBlbGluZS wgcGFydGlj dWxhcmx5IG lmIGl0IHJl bGllcyBoZW F2aWx5IG9u IGEgZmV3IG Jsb2NrYnVz dGVyIHByb2 R1Y3RzLiBJ ZiB0aGUgY2 9tcGFueSBl eHBlcmllbm NlcyBzaWdu aWZpY2FudC BzZXRiYWNr cyBpbiBjbG luaWNhbCB0 cmlhbHMgb3 IgcmVndWxh dG9yeSBhcH Byb3ZhbHMg Zm9yIGl0cy BsZWFkaW5n IHRoZXJhcG llcyBvciBp ZiBpdCBmYW NlcyBjb21w ZXRpdGlvbi Bmcm9tIGdl bmVyaWMgZH J1Z3Mgb3Ig Ymlvc2ltaW xhcnMsIHRo aXMgY291bG QgbGVhZCB0 byBhIHN1Yn N0YW50aWFs IGRlY2xpbm UgaW4gcmV2 ZW51ZXMuID xicj5JbiB0 aGlzIHNpdH VhdGlvbiwg dGhlIGNvbX BhbnnigJlz IG1hcmdpbn MgY291bGQg c2hyaW5rIH NpZ25pZmlj YW50bHkgZH VlIHRvIHJl ZHVjZWQgc2 FsZXMgYW5k IGluY3JlYX NlZCBwcmVz c3VyZSBvbi BwcmljaW5n LiBXaXRoIG xvd2VyIHJl dmVudWVzLC BLeW93YSBL aXJpbiB3b3 VsZCBsaWtl bHkgaGF2ZS B0byBtYW5h Z2UgaXRzIG 9wZXJhdGlu ZyBjb3N0cy Btb3JlIGFn Z3Jlc3Npdm VseSwgYnV0 IGlmIGZpeG VkIGNvc3Rz IHJlbWFpbi BoaWdoIGFu ZCBSJmFtcD tEIGV4cGVu c2VzIGNvbn RpbnVlLCB0 aGF0IHdvdW xkIGxlYWQg dG8gaW5jcm Vhc2VkIGxv c3Nlcy4gPG JyPkNhc2gg ZmxvdyB3b3 VsZCBhbHNv IGJlIG5lZ2 F0aXZlbHkg aW1wYWN0ZW QuIElmIHRo ZSBjb21wYW 55IGlzIHVu YWJsZSB0by BicmluZyBu ZXcgcHJvZH VjdHMgdG8g bWFya2V0IH N1Y2Nlc3Nm dWxseSwgaX QgbWF5IHN0 cnVnZ2xlIH RvIGdlbmVy YXRlIHN1Zm ZpY2llbnQg Y2FzaCBmcm 9tIG9wZXJh dGlvbnMuIE FkZGl0aW9u YWxseSwgaW YgdGhlIGNv bXBhbnkgaG FzIG9uZ29p bmcgY29tbW l0bWVudHMg Zm9yIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCwg aXQgd2lsbC BuZWVkIHRv IG1haW50YW luIHNwZW5k aW5nIGluIH RoZXNlIGFy ZWFzIGV2ZW 4gd2hlbiBy ZXZlbnVlcy BhcmUgZGVj bGluaW5nLC BmdXJ0aGVy IHN0cmFpbm luZyBjYXNo IGZsb3cuPG JyPk9uIHRo ZSBiYWxhbm NlIHNoZWV0 LCBhIHByb2 xvbmdlZCBk ZWNsaW5lIG luIHJldmVu dWVzIGNvdW xkIGxlYWQg dG8gYSBzaW duaWZpY2Fu dCBkcm9wIG luIGFzc2V0 IHZhbHVlcy wgcGFydGlj dWxhcmx5IG lmIHRoZSBj b21wYW55IG hhcyBtYWRl IHN1YnN0YW 50aWFsIGlu dmVzdG1lbn RzIGluIFIm YW1wO0QgYW 5kIGluZnJh c3RydWN0dX JlLiBJZiBj YXNoIHJlc2 VydmVzIGRl cGxldGUgZH VlIHRvIG5l Z2F0aXZlIG Nhc2ggZmxv d3MsIEt5b3 dhIEtpcmlu IG1heSBmaW 5kIGl0c2Vs ZiBpbiBhIH Bvc2l0aW9u IHdoZXJlIG l0IG11c3Qg dGFrZSBvbi BhZGRpdGlv bmFsIGRlYn QgdG8gZmlu YW5jZSBvcG VyYXRpb25z LCB3aGljaC Bjb3VsZCBs ZWFkIHRvIG EgZGV0ZXJp b3JhdGlvbi BpbiBpdHMg ZGVidC10by 1lcXVpdHkg cmF0aW8uID xicj5VbHRp bWF0ZWx5LC BpZiB0aGlz IHNjZW5hcm lvIHBsYXlz IG91dCwgS3 lvd2EgS2ly aW7igJlzIG ZpbmFuY2lh bCBoZWFsdG ggY291bGQg YmUgY29tcH JvbWlzZWQs IHJlc3VsdG luZyBpbiBy ZXN0cmljdG VkIG9wZXJh dGlvbmFsIG ZsZXhpYmls aXR5LCBwb3 RlbnRpYWwg bGF5b2Zmcy wgYW5kIGEg ZGltaW5pc2 hlZCBjYXBh Y2l0eSB0by BpbnZlc3Qg aW4gZnV0dX JlIGdyb3d0 aCwgZnVydG hlciBpbXBh aXJpbmcgaX RzIHJlcHV0 YXRpb24gaW 4gdGhlIHBo YXJtYWNldX RpY2FsIG1h cmtldC48Yn I+
Interesting facts about the company
π Want to read more about Kyowa Kirin?
Sign up for free
or
log in
π Donβt miss "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvaF p2dnlOeWVR OUJRM1pTS0 pUOXIud2Vi cCIgYWx0PS JLeW93YSBL aXJpbiIgdG l0bGU9Ikt5 b3dhIEtpcm luIiAgY2xh c3M9ImltZy 1mbHVpZCIg aGVpZ2h0PT UwIHdpZHRo PTUwIGxvYW Rpbmc9J2xh enknIHN0eW xlPSdib3Jk ZXItcmFkaX VzOiA2cHg7 Jz4KCiAgIC AgICAgICAg ICAgICAgIC AgPGRpdiBz dHlsZT0nZm xleDogMTsg dGV4dC1hbG lnbjogY2Vu dGVyOyBtYX JnaW4tbGVm dDogNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdm b250LXNpem U6IDI2cHg7 IGNvbG9yOi AjMzMzOyBt YXJnaW4tYm 90dG9tOiAx NXB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICDwn5 OIIFdhbnQg dG8gcmVhZC Btb3JlIGFi b3V0IEt5b3 dhIEtpcmlu PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+GkyBE aXNjb3Zlci A8aT4iVGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2NrcyI8 L2k+IOKAlC BmcmVlIGVC b29rIQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 L3A+CgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 IS0tCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxk aXYgc3R5bG U9J21hcmdp bi10b3A6ID EycHg7IGZv bnQtc2l6ZT ogMTNweDsg Y29sb3I6IC M0NDQ7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIFNp Z24gdXAgbm 93IGFuZCBn ZXQgb3VyIG ZyZWUgZUJv b2sgCiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8Yj5UaG UgQ2hlY2ts aXN0IFZhbH VlIEludmVz dG9yIOKAlC BBIFNtYXJ0 ZXIgV2F5IH RvIFBpY2sg U3RvY2tzPC 9iPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgLS 0+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwhLS 0KICAgICAg ICAgICAgIC AgICAgICAg ICAgPGRpdi BzdHlsZT0n bWFyZ2luLX RvcDogMTZw eDsgZm9udC 1zaXplOiAx NHB4OyBjb2 xvcjogIzQ0 NDsgZm9udC 1mYW1pbHk6 IC1hcHBsZS 1zeXN0ZW0s IEJsaW5rTW FjU3lzdGVt Rm9udCwgU2 Vnb2UgVUks IFJvYm90by wgSGVsdmV0 aWNhIE5ldW UsIHNhbnMt c2VyaWY7IG xpbmUtaGVp Z2h0OiAxLj Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIEhhdmUg eW91IGhlYX JkIGFib3V0 IG91ciBzaG 9ydCA8c3Ry b25nIHN0eW xlPSdmb250 LXdlaWdodD ogNjAwOyc+ RGFpbHkgVm lkZW8gTmV3 c2xldHRlcj wvc3Ryb25n Pj8KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxhIGhyZW Y9J2h0dHBz Oi8vd3d3Lm luc2lnaHRm dWx2YWx1ZS 5jb20vbmV3 c2xldHRlci 5waHAnIHRh cmdldD0nX2 JsYW5rJyBz dHlsZT0nY2 9sb3I6ICMw MDdCRkY7IH RleHQtZGVj b3JhdGlvbj ogbm9uZTsg Zm9udC13ZW lnaHQ6IDUw MDsgbWFyZ2 luLWxlZnQ6 IDZweDsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIEZpbmQg b3V0IG1vcm UKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC 0tPgogICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICAKICAgIC AgICAKICAg ICAgICA8c3 BhbiBjbGFz cz0nYmx1cn JlZC10ZXh0 Jz4KICAgIC AgICAgICAg NG9DaUlFdD ViMyBkaElF dHBjbWx1IE lHbHpJR0Vn U20gRndZVz VsYzJVZyBj R2hoY20xaF kyIFYxZEds allXd2cgWT I5dGNHRnVl UyBCMGFHRj BJSGRoIGN5 Qm1iM1Z1Wk cgVmtJR2x1 SURFNSBORG t1SUR4aWNq IDdpZ0tJZ1 ZHaGwgSUdO dmJYQmhibi BuaWdKbHpJ RzVoIGJXVW dZMjl0Wlgg TWdabkp2Yl NCaCBJR052 YldKcGJtIE YwYVc5dUlH OW0gSUdsMG N5QnZjbSBs bmFXNWhiQ0 JtIGIzVnVa R1Z5YysgS0 FtU0J6ZFhK dSBZVzFsY3 l3Z1MzIGx2 ZDJFZ1lXNW sgSUV0cGNt bHVMaiB4aW NqN2lnS0ln IFZHaGxJR0 52YlggQmhi bm5pZ0psei BJR1pwY25O MElIIEJ5Yj JSMVkzUWcg ZDJGeklHRW daRyBsblpY TjBhWFpsIE lHVnVlbmx0 WlMgQnpkWE J3YkdWdCBa VzUwSUcxaF pHIFVnWm5K dmJTQmkgYV hSMFpYSWdi VyBWc2IyNG daWGgwIGNt RmpkQzRnUE cgSnlQdUtB b2lCSiBiaU F4T1RVekxD IEJMZVc5M1 lTQkwgYVhK cGJpQmxlSC BCaGJtUmxa Q0JwIGJuUm xjbTVoZEcg bHZibUZzYk hrZyBZbmtn YjNCbGJtIG x1WnlCaElI TjEgWW5OcF pHbGhjbiBr Z2FXNGdUbV YzIElGbHZj bXNnUTIgbD BlU0JqWVd4 cyBaV1FnUz NsdmQyIEVn VUdoaGNtMW ggWTJWMWRH bGpZVyB3c0 lFbHVZeTRn IFBHSnlQdU tBb2kgQlVh R1VnWTI5dC BjR0Z1ZVNC a1pYIFpsYk c5d1pXUWcg U21Gd1lXN2 lnSiBseklH WnBjbk4wIE lHaDFiV0Z1 SUcgMTVaV3 h2YldFZyBZ MlZzYkNCc2 FXIDVsSUda dmNpQmggYm 5ScFltOWtl UyBCd2NtOW tkV04wIGFX OXVMQ0IzYU cgbGphQ0Jw Y3lCeiBkR2 xzYkNCMWMy IFZrSUdsdU lISmwgYzJW aGNtTm9JRy BGdVpDQmta WFpsIGJHOX diV1Z1ZEMg QjBiMlJoZV M0ZyBQR0p5 UHVLQW9pIE JKYmlCMGFH VWcgTVRrM0 1ITXNJRSB0 NWIzZGhJRX RwIGNtbHVJ SGRoY3kgQn ZibVVnYjJZ ZyBkR2hsSU dacGNuIE4w SUdOdmJYQm ggYm1sbGN5 QjBieSBCa1 pYWmxiRzl3 IElHRWdibT l1TFggTjBa WEp2YVdSaC BiQ0JoYm5S cExXIGx1Wm 14aGJXMWgg ZEc5eWVTQm tjbiBWbklD aE9VMEZKIF JDa2dZMkZz YkcgVmtJR3 h2ZUc5dyBj bTltWlc0dU lEIHhpY2o3 aWdLSWcgVk dobElHTnZi WCBCaGJua2 dhWE1nIFlT QnNaV0ZrWl ggSWdhVzRn WW1sdiBjR2 hoY20xaFky IFYxZEdsal lXeHogSUdG dVpDQm9ZWC BNZ1ltVmxi aUJwIGJuWn ZiSFpsWkMg QnBiaUIwYU dVZyBaR1Yy Wld4dmNHID FsYm5RZ2Iy WWcgYlhWc2 RHbHdiRyBV Z1lXNTBhV0 p2IFpIa2dZ VzVrSUggQm xjSFJwWkdV dCBZbUZ6Wl dRZ2RHIGhs Y21Gd2FXVn ogTGlBOFlu SSs0byBDaU lFdDViM2Ro IElFdHBjbW x1SUcgaGhj eUJoSUhOMC BjbTl1WnlC bmJHIDlpWV d3Z2NISmwg YzJWdVkyVX NJSCBkcGRH Z2djM1ZpIG MybGthV0Z5 YVcgVnpJR0 Z1WkNCdiBa bVpwWTJWek lHIGx1SUc5 MlpYSWcgTX pBZ1kyOTFi biBSeWFXVn pMaUE4IFlu SSs0b0NpSU YgUm9aU0Jq YjIxdyBZVz U1SUdadlkz IFZ6WlhNZ2 IyNGcgY21W elpXRnlZMi BnZ1lXNWtJ R1JsIGRtVn NiM0J0Wlcg NTBJR2x1SU dGeSBaV0Z6 SUhOMVkyIG dnWVhNZ2Iy NWogYjJ4dl oza3NJRyA1 bGNHaHliMn h2IFoza3NJ R2x0YlggVn ViMnh2WjNr cyBJR0Z1Wk NCeVlYIEps SUdScGMyVm ggYzJWekxp QThZbiBJKz RvQ2lJRWx1 IElHRmtaR2 wwYVcgOXVJ SFJ2SUhCby BZWEp0WVdO bGRYIFJwWT JGc2N5d2cg UzNsdmQyRW dTMiBseWFX NGdZV3h6IG J5QndjbTlr ZFcgTmxjeU JoYm1RZyBi V0Z5YTJWMG N5IEJ0WldS cFkyRnMgSU dSbGRtbGpa WCBNc0lHSn BiM05wIGJX bHNZWEp6TE MgQmhibVFn YjNabCBjaT EwYUdVdFky IDkxYm5SbG NpQncgY205 a2RXTjBjeS A0PQogICAg ICAgIDwvc3 Bhbj4KICAg ICAgICAKIC AgICAgICA=
See Company Q&A
π Get full analytics about Kyowa Kirin
Sign up for free
or
log in
π Unlock our free guide: "The Checklist Value Investor β A Smarter Way to Pick Stocks"